Wednesday, November 25, 2009, 2:30am SGT - The Singapore stock market opens in 6 hours and 30 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Watson Pharmaceuticals Inc. (WPI)

At 2:15AM SGT: 36.865002 USD  Up 1.315002 (3.70%)  
 MORE ON WPI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 WATSON PHARMACEUTCLS (NYSE:WPI) Delayed quote dataEdit
Last Trade:36.865002 USD
Trade Time:2:15AM SGT
Change:Up 1.315002 (3.70%)
Prev Close:35.549999
Open:36.07
Bid:N/A
Ask:N/A
1y Target Est:37.50
Day's Range:35.900002 - 36.98
52wk Range:21.77 - 38.48
Volume:907,348
Avg Vol (3m):1,030,820
Market Cap:3.91B
P/E (ttm):19.00
EPS (ttm):1.94
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add WPI to Portfolio   Download Data

 HEADLINES 
•Israel Stocks: Tel Aviv broadly higher; Israel Chemicals in focus
at MarketWatch (Mon, Nov 23)
•StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
GlobeNewswire (Wed, Nov 18)
•Watson Names Robert A. Stewart Senior Vice President, Global Operations
PR Newswire (Mon, Nov 16)
•WATSON PHARMACEUTICALS INC Financials
EDGAR Online Financials (Fri, Nov 13)
•Cephalon, Barr settle Fentora dispute
AP (Fri, Nov 13)
•UPDATE - Cephalon, Barr settle patent infringement suit
at Reuters (Fri, Nov 13)
•Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference
PR Newswire (Wed, Nov 11)
•Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter
at Seeking Alpha (Mon, Nov 9)
•Cephalon's Upside and Downside
at Seeking Alpha (Sun, Nov 8)
•WATSON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 7)
•Watson to Present at Credit Suisse Healthcare Conference
PR Newswire (Sat, Nov 7)
•Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray
Wall Street Transcript (Fri, Nov 6)
More Headlines for WPI...
 ANALYST 
EPS Est (next year) (Dec-09) :2.57
EPS Est (in 2 years) (Dec-10) :2.65
Avg Rec (current)*:2.8
PEG Ratio:1.14
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices